Fresh analysis reveals that individuals who stop using blockbuster weight-loss injections like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop conventional diet and exercise plans.
Findings released in a prominent health publication demonstrates that while obese people frequently drop substantial amounts of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals buying such treatments need to be aware of the risk of rapid weight regain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment mass in about one and a half years.
Comparing Therapies
The research, which looked at dozens of trials involving over 9,000 of participants, compared the results of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through diet and exercise typically have a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Doctors believe the way of the injections accounts for the accelerated weight return.
The injections mimic a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' means appetite is unsuppressed, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts argue that, considering the high risk of relapse, the therapy is often ongoing.
This opinion is echoed by drug manufacturers, who note that the findings "underscore the persistent character of obesity," similar to managing conditions like diabetes.
Patient Accounts
People who have stopped the jabs report a intense return of appetite.
"It felt as if a switch that goes on and you're instantly starving," recalled an individual.
This difficulty is exacerbated if users have not adopted lasting lifestyle or habit changes during therapy.
Widespread Adoption
Recent estimates show that millions of people in the UK have tried these injections in the past year, with demand remaining high.
- Use is more common among women than men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Finally, researchers stress that while these medications are powerful tools for weight loss, they are not a standalone fix and long-term success relies on integrated lifestyle support.
